To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Motif Neurotech, one of the ...

Motif Neurotech, a brain-computer interface (BCI) company developing technologies for mental health, today announced that its patient registry is now live and accepting submissions from individuals ...

After announcing last September that it had logged the first successful implantation of its pea-sized neurostimulator for depression, Motif Neurotech has raised $18.75 million in venture capital funds ...

Rice University engineers have developed the smallest implantable brain stimulator demonstrated in a human patient. Thanks to pioneering magnetoelectric power transfer technology, the pea-sized device ...

A number of pivotal announcements this year – including Neuralink’s first brain implant trial, and major funding rounds from companies such as Motif Neurotech with its miniaturized neurostimulator for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In addition to revealing plans ...

Engineers have developed the smallest implantable brain stimulator demonstrated in a human patient that could revolutionize treatment for drug-resistant depression and other psychiatric or ...

The positions in the table below reflect the Motif Neurotech's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

HOUSTON--(BUSINESS WIRE)--Motif Neurotech, a Houston-based neurotechnology company, today announced their selection by UK’s Advanced Research and Invention Agency (ARIA) for multimillion dollar award ...

Jacob Robinson (top left) with members of his Rice lab; Motif Neurotech is developing the Digitally programmable Over-brain Therapeutic (DOT), a pea-sized, wirelessly-powered implantable brain ...

Rice University’s Jacob Robinson and his team of researchers have developed the smallest implantable brain stimulator demonstrated in a human patient that could revolutionize treatment for ...